Invention Grant
- Patent Title: Targeted inhibition using engineered oligonucleotides
-
Application No.: US18155163Application Date: 2023-01-17
-
Publication No.: US12104157B2Publication Date: 2024-10-01
- Inventor: Robert Place , Anthony Saleh , Tishan Williams
- Applicant: miRecule, Inc.
- Applicant Address: US MD Gaithersburg
- Assignee: miRecule, Inc.
- Current Assignee: miRecule, Inc.
- Current Assignee Address: US MD Gaithersburg
- Agent David H Vance
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K31/7088 ; A61K47/54 ; C12N15/113
Abstract:
Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
Public/Granted literature
- US20230295626A1 Targeted Inhibition Using Engineered Oligonucleotides Public/Granted day:2023-09-21
Information query
